This inventor holds 3 USPTO granted patents and 8 published patent applications and 4 EPO patents. Top assignee: Acorda Therapeutics, Inc.. Active years: 2015-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015-2022
Title: Anindita Ganguly: Innovator in Heart Failure Treatment
Introduction
Anindita Ganguly is a notable inventor based in White Plains, NY (US), recognized for her contributions to medical innovations. With a total of three patents to her name, she has made significant strides in the field of heart failure treatment.
Latest Patents
One of her latest patents focuses on the therapeutic dosing of a neuregulin or a subsequence thereof for the treatment or prophylaxis of heart failure. This invention is directed towards establishing a dosing regimen that maintains and enhances the therapeutic benefits of administering a neuregulin, such as glial growth factor 2 (GGF2), while minimizing potential side effects. This innovative approach aims to improve the quality of life for mammals suffering from heart failure.
Career Highlights
Anindita Ganguly is currently associated with Acorda Therapeutics, Inc., where she continues to develop groundbreaking treatments. Her work is pivotal in advancing therapeutic options for heart failure, showcasing her dedication to improving patient outcomes.
Collaborations
Anindita collaborates with esteemed colleagues, including Anthony O Caggiano and Jennifer Iaci, who contribute to her innovative projects and research endeavors.
Conclusion
Anindita Ganguly's work in the field of heart failure treatment exemplifies her commitment to medical innovation. Her patents and collaborations highlight her significant impact on healthcare advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile